---
layout: post
title: "Type VII Veterinary Master File for Research and Development and Risk Reviews; Draft Guidance for Industry; Availability"
date: 2026-02-04 21:49:32 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-31531
original_published: 2025-01-07 00:00:00 +0000
significance: 8.00
---

# Type VII Veterinary Master File for Research and Development and Risk Reviews; Draft Guidance for Industry; Availability

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** January 07, 2025 00:00 UTC
**Document Number:** 2024-31531

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry (GFI) #260 entitled "Type VII Veterinary Master File for Research and Development and Risk Reviews." This draft guidance, when finalized, will describe FDA's current thinking regarding the use of Type VII Veterinary Master Files (Type VII VMFs). Type VII VMFs are appropriate for research and development of animal cells, tissues, and cell- and tissue-based products (ACTPs), gene therapies, and heritable intentional genomic alterations (IGAs) in animals.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/01/07/2024-31531/type-vii-veterinary-master-file-for-research-and-development-and-risk-reviews-draft-guidance-for)
- API: https://www.federalregister.gov/api/v1/documents/2024-31531

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
